Improving Outcomes in High-Risk Percutaneous Coronary Interventions and Newer-Generation Drug-Eluting Stents: Good, But Not Good Enough

Publisher： Karger

E-ISSN： 1421-9751|138|2|73-75

ISSN： 0008-6312

Source： Cardiology, Vol.138, Iss.2, 2017-06, pp. : 73-75

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Three-Year Clinical Outcome of Patients with Coronary Disease and Increased Event Risk Treated with Newer-Generation Drug-Eluting Stents: From the Randomized DUTCH PEERS Trial

By  

Cardiology, Vol. 137, Iss. 4, 2017-04 ,pp. : 207-217

Karger

Access to resources Recommend Favorite

Extended follow‐up following “full‐metal jacket” percutaneous coronary interventions with drug‐eluting stents

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 84, Iss. 7, 2014-12 ,pp. : 1042-1050

John Wiley & Sons Inc

Access to resources Recommend Favorite

Drug‐eluting stents: Newer is better!

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 84, Iss. 7, 2014-12 ,pp. : 1061-1061

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of high lipoprotein(a) levels on in‐stent restenosis and long‐term clinical outcomes of angina pectoris patients undergoing percutaneous coronary intervention with drug‐eluting stents in Asian population

By  

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (ELECTRONIC), Vol. 42, Iss. 6, 2015-06 ,pp. : 588-595

John Wiley & Sons Inc

Access to resources Recommend Favorite

Gender disparity in the use of drug‐eluting stents during percutaneous coronary intervention for acute myocardial infarction

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 86, Iss. 2, 2015-08 ,pp. : 221-228

John Wiley & Sons Inc

Access to resources Recommend Favorite